115 related articles for article (PubMed ID: 19027954)
1. Differences between Pseudomonas aeruginosa in a clinical sample and in a colony isolated from it: comparison of virulence capacity and susceptibility of biofilm to inhibitors.
Ramos AN; Peral MC; Valdez JC
Comp Immunol Microbiol Infect Dis; 2010 May; 33(3):267-75. PubMed ID: 19027954
[TBL] [Abstract][Full Text] [Related]
2. Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment.
Valdéz JC; Peral MC; Rachid M; Santana M; Perdigón G
Clin Microbiol Infect; 2005 Jun; 11(6):472-9. PubMed ID: 15882197
[TBL] [Abstract][Full Text] [Related]
3. Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control.
Bjarnsholt T; Tolker-Nielsen T; Høiby N; Givskov M
Expert Rev Mol Med; 2010 Apr; 12():e11. PubMed ID: 20370936
[TBL] [Abstract][Full Text] [Related]
4. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.
Pinna A; Usai D; Sechi LA; Molicotti P; Zanetti S; Carta A
Cornea; 2008 Apr; 27(3):320-6. PubMed ID: 18362661
[TBL] [Abstract][Full Text] [Related]
5. Protamine sulfate reduces the susceptibility of thermally injured mice to Pseudomonas aeruginosa infection.
Haynes A; Rumbaugh KP; Park PW; Hamood AN; Griswold JA
J Surg Res; 2005 Jan; 123(1):109-17. PubMed ID: 15652958
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of potential virulence markers in Pseudomonas aeruginosa isolated from drinking water.
Silva ME; Filho IC; Endo EH; Nakamura CV; Ueda-Nakamura T; Filho BP
Antonie Van Leeuwenhoek; 2008 May; 93(4):323-34. PubMed ID: 18038252
[TBL] [Abstract][Full Text] [Related]
7. Effect of macrophage secretory products on elaboration of virulence factors by planktonic and biofilm cells of Pseudomonas aeruginosa.
Mittal R; Sharma S; Chhibber S; Harjai K
Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):12-26. PubMed ID: 16427697
[TBL] [Abstract][Full Text] [Related]
8. Comparison of antibiotic susceptibility and plasmid content, between biofilm producing and non-producing clinical isolates of Pseudomonas aeruginosa.
Delissalde F; Amábile-Cuevas CF
Int J Antimicrob Agents; 2004 Oct; 24(4):405-8. PubMed ID: 15380270
[TBL] [Abstract][Full Text] [Related]
9. Subinhibitory concentrations of phenyl lactic acid interfere with the expression of virulence factors in Staphylococcus aureus and Pseudomonas aeruginosa clinical strains.
Chifiriuc MC; Diţu LM; Banu O; Bleotu C; Drăcea O; Bucur M; Larion C; Israil AM; Lazăr V
Roum Arch Microbiol Immunol; 2009; 68(1):27-33. PubMed ID: 19507624
[TBL] [Abstract][Full Text] [Related]
10. Antipathogenic properties of Lactobacillus plantarum on Pseudomonas aeruginosa: the potential use of its supernatants in the treatment of infected chronic wounds.
Ramos AN; Cabral ME; Noseda D; Bosch A; Yantorno OM; Valdez JC
Wound Repair Regen; 2012; 20(4):552-62. PubMed ID: 22642376
[TBL] [Abstract][Full Text] [Related]
11. Silver against Pseudomonas aeruginosa biofilms.
Bjarnsholt T; Kirketerp-Møller K; Kristiansen S; Phipps R; Nielsen AK; Jensen PØ; Høiby N; Givskov M
APMIS; 2007 Aug; 115(8):921-8. PubMed ID: 17696948
[TBL] [Abstract][Full Text] [Related]
12. Ginseng aqueous extract attenuates the production of virulence factors, stimulates twitching and adhesion, and eradicates biofilms of Pseudomonas aeruginosa.
Alipour M; Omri A; Suntres ZE
Can J Physiol Pharmacol; 2011 Jun; 89(6):419-27. PubMed ID: 21815782
[TBL] [Abstract][Full Text] [Related]
13. Otopathogenic Pseudomonas aeruginosa strains as competent biofilm formers.
Wang EW; Jung JY; Pashia ME; Nason R; Scholnick S; Chole RA
Arch Otolaryngol Head Neck Surg; 2005 Nov; 131(11):983-9. PubMed ID: 16301370
[TBL] [Abstract][Full Text] [Related]
14. Chronic Pseudomonas aeruginosa biofilm infection impairs murine S100A8/A9 and neutrophil effector cytokines-implications for delayed wound closure?
Trøstrup H; Lerche CJ; Christophersen LJ; Thomsen K; Jensen PØ; Hougen HP; Høiby N; Moser C
Pathog Dis; 2017 Sep; 75(7):. PubMed ID: 28645160
[TBL] [Abstract][Full Text] [Related]
15. Use of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 biofilms.
Pires D; Sillankorva S; Faustino A; Azeredo J
Res Microbiol; 2011 Oct; 162(8):798-806. PubMed ID: 21782936
[TBL] [Abstract][Full Text] [Related]
16. Quantitative comparison and analysis of species-specific wound biofilm virulence using an in vivo, rabbit-ear model.
Seth AK; Geringer MR; Galiano RD; Leung KP; Mustoe TA; Hong SJ
J Am Coll Surg; 2012 Sep; 215(3):388-99. PubMed ID: 22704819
[TBL] [Abstract][Full Text] [Related]
17. Experimental infection with Pseudomonas aeruginosa in mice. II. The fate of highly and low virulent strains in the peritoneal cavity and organs of mice.
Kobayashi F
Jpn J Microbiol; 1971 Jul; 15(4):301-7. PubMed ID: 5000615
[No Abstract] [Full Text] [Related]
18. [Analysis of susceptibility of Pseudomonas aeruginosa isolated from a burn ward to antibiotics in vitro].
Zhang YH; Deng SL; Liu JW
Zhonghua Shao Shang Za Zhi; 2005 Apr; 21(2):104-6. PubMed ID: 15938955
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of the biological characteristics of mucoid and non-mucoid Pseudomonas aeruginosa strains isolated from chronic respiratory infections.
Meitert E; Sima F; Savulian C; Chersulick E; Sălăgeanu A
Arch Roum Pathol Exp Microbiol; 1989; 48(3):193-207. PubMed ID: 2519631
[TBL] [Abstract][Full Text] [Related]
20. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
Lee MY; Ko KS; Song JH; Peck KR
J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
